Marijuana won’t be downgraded from Schedule 1 to Schedule 3 of the Controlled Substances Act until December at the earliest, according to a U.S. Drug Enforcement Administration notice. DEA: Marijuana rescheduling hearing won’t happen until after general election is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Regulators said that many companies waited until the last minute to submit new designs for approval. The post New Missouri cannabis packaging deadline set for Sunday appeared first on Green Market Report.

The state task force padlocked a total of 345 stores following 789 inspections during its three-month tenure. The post New York state cannabis task force wraps up, city’s crackdown to continue appeared first on Green Market Report.

The agency disputed claims that there was a widespread backlog of renewal approvals. The post Oklahoma cannabis industry stakeholders cry foul over licensing renewal ‘backlog’ appeared first on Green Market Report.

      The Drug Enforcement Administration (DEA) has scheduled a hearing to consider differing expert opinions on the Justice Department’s proposal to federally reschedule marijuana—a hearing that will take place after the November election. After moving to reclassify cannabis as a Schedule III drug under the Controlled Substances Act (CSA) back in March, DOJ opened a 60-day  ​ 

Medical marijuana sales in Arkansas are down nearly 4% this year compared to the same period in 2023. Arkansas medical cannabis sales down 4% from last year is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs